{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:00:33Z","timestamp":1787238033135,"version":"build-2736575974"},"reference-count":165,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":4978,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.anpedi.2012.10.002","type":"journal-article","created":{"date-parts":[[2012,11,24]],"date-time":"2012-11-24T06:01:56Z","timestamp":1353736916000},"page":"59.e1-59.e27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Calendario de vacunaciones de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones 2013"],"prefix":"10.1016","volume":"78","author":[{"given":"D.","family":"Moreno-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"\u00c1lvarez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ar\u00edstegui Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Barrio Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Cilleruelo Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Corretger Rauet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gonz\u00e1lez-Hachero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hern\u00e1ndez-Sampelayo Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Merino Mo\u00edna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ortigosa del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ruiz-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2012.10.002_bib0005","doi-asserted-by":"crossref","first-page":"42.e21","DOI":"10.1016\/j.anpedi.2011.10.007","article-title":"Calendario de vacunaciones de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones 2012","volume":"76","author":"Moreno-P\u00e9rez","year":"2012","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0010","unstructured":"Calendarios de vacunaci\u00f3n de las ciudades y comunidades aut\u00f3nomas espa\u00f1olas [consultado 30 Sept 2012]. Disponible en: http:\/\/www.aepap.org\/vacunas\/calendarios-espanoles"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0015","first-page":"1","article-title":"Recommended immunization schedules for persons aged 0 through 18 years-United States, 2012","volume":"61","year":"2012","journal-title":"MMWR"},{"issue":"RR16","key":"10.1016\/j.anpedi.2012.10.002_bib0020","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP); Part 1: Immunization of infants, children, and adolescents","volume":"54","year":"2005","journal-title":"MMWR"},{"issue":"RR02","key":"10.1016\/j.anpedi.2012.10.002_bib0025","first-page":"1","article-title":"General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) [consultado 30 Sept 2012]","volume":"60","year":"2011","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0030","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jhep.2012.05.021","article-title":"Minimization of HBV infection by a 25-year universal vaccination program","volume":"57","author":"Ni","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0035","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2165\/11204830-000000000-00000","article-title":"DTPa-HBV-IPV\/Hib vaccine (Infanrix Hexa\u2122). A review of its use as primary and booster vaccination","volume":"70","author":"Dhillon","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005530.pub3","article-title":"Combined DTP-HBV-HIV vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenza B (HIB) [consultado 30 Sept 2012]","author":"Bar-On","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0045","first-page":"161","article-title":"Haut Conseil de la sant\u00e9 publique. Le calendrier des vaccinations et les recommandations vaccinales 2012 selon l\u2019avis du haut Conseil de la sant\u00e9 publique","volume":"14-15","author":"Floret","year":"2012","journal-title":"BEH"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0050","unstructured":"Ponencia de Programa y Registro de vacunaciones 4 de febrero del 2010. Propuesta de recomendaci\u00f3n para la sustituci\u00f3n de la vacuna DTPa, como quinta dosis por una vacuna dTpa en el calendario de vacunaci\u00f3n infantil recomendado por el CISNS. Documento interno de 16 de febrero del 2010 [consultado 30 Sept 2012]. Disponible en: http:\/\/www.aragon.es\/estaticos\/GobiernoAragon\/Departamentos\/SaludConsumo\/Profesionales\/13_SaludPublica\/20_Programas_Salud\/Propuesta_recomendacion_sustitucion_vacuna_DTPa.pdf"},{"issue":"RR17","key":"10.1016\/j.anpedi.2012.10.002_bib0055","first-page":"1","article-title":"Preventing tetanus, diphteria, and pertussis among adults: Use of tetanus toxoid, reduced diphteria toxoid and acellular pertussis vaccine","volume":"55","year":"2006","journal-title":"MMRW"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0060","unstructured":"Organizaci\u00f3n Mundial de la Salud. Calendarios del mundo [consultado 30 Sept 2012]. Disponible en: http:\/\/apps.who.int\/immunization_monitoring\/en\/globalsummary\/ScheduleSelect.cfm"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0065","unstructured":"ECDC. Pertussis vaccination overview in European countries [consultado 30 Sept 2012]. Disponible en: http:\/\/ecdc.europa.eu\/en\/activities\/surveillance\/euvac\/schedules\/Pages\/pertussis_schedule.aspx"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0070","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","article-title":"Waning protection after fifth dose of acellular pertussis vaccine in children","volume":"367","author":"Klein","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0075","unstructured":"Ministerio de Sanidad y Consumo. Vacunaci\u00f3n en adultos. Recomendaciones vacuna de la difteria y t\u00e9tanos. Actualizaci\u00f3n 2009 [consultado 30 Sept 2012]. 2009. Documento aprobado por la Direcci\u00f3n General de Salud P\u00fablica. 18 de Febrero del 2009. Disponible en: http:\/\/www.msc.es\/ciudadanos\/proteccionSalud\/vacunaciones\/docs\/TetanosDifteria_2009.pdf (\u00faltimo acceso)."},{"key":"10.1016\/j.anpedi.2012.10.002_bib0080","series-title":"ECDC Guidance. Scientific panel on childhood immunization schedule: diphteria-tetanus-pertusis (DTP) vaccination","year":"2009"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0085","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(11)70007-X","article-title":"Rational pertusis booster vaccination throughout life in Europe","volume":"11","author":"Zepp","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0090","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1542\/peds.2011-2594","article-title":"Why do pertussis vaccines fail?","volume":"129","author":"Cherry","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0095","first-page":"468","article-title":"Updated Recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older-Advisory Committee on Immunization Practices (ACIP), 2012","volume":"61","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0100","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1542\/peds.2007-3025","article-title":"Potencial impact of acceleration of pertussis vaccine primary series for infants","volume":"122","author":"Shinall","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/INF.0b013e3181f43906","article-title":"Severe pertussis in infants: estimated impact of first vaccine dose at 6 versus 8 weeks in Australia","volume":"30","author":"Foxwell","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14760584.8.2.153","article-title":"Pertusis vaccination in newborns","volume":"8","author":"Ulloa Gutierrez","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/cid\/ciq001","article-title":"Implementation of cocooning against pertusis in high-risk population","volume":"52","author":"Healy","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0120","first-page":"1","article-title":"New pertussis vaccination approaches: en route to protect newborns?","author":"Locht","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0125","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jpeds.2007.09.034","article-title":"Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants","volume":"152","author":"Knuf","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/MOP.0b013e32834e8fe9","article-title":"Cocooning: a concept to protect young children from infectious diseases","volume":"24","author":"Grizas","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0135","first-page":"1424","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged < 12 months","volume":"60","year":"2011","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0140","unstructured":"The Joint Committee on Vaccination and Immunisation (JCVI). Temporary programme of pertussis (whooping cough) vaccination of pregnant women, September 27th 2012 [consultado 30 Sept 2012]. Disponible en: https:\/\/www.wp.dh.gov.uk\/publications\/files\/2012\/09\/CMO-Pertussis-27-09-2012-FINAL.pdf."},{"key":"10.1016\/j.anpedi.2012.10.002_bib0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vaccine.2010.10.025","article-title":"A decennial booster dose of reduced antigen content diphteria, tetanus, acellular pertusis vaccine (Boostrix\u2122) is immunogenic and well tolerated in adults","volume":"29","author":"Booy","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0150","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/655825","article-title":"Deccenial administration of a reduced antigen content diphteria and tetanus toxoids and acelular pertusis vaccine in young adults","volume":"51","author":"Mertsola","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0155","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/CMR.00003-08","article-title":"Pertusis vaccination for health care workers","volume":"21","author":"Sandora","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0160","unstructured":"Ministerio de Sanidad y Consumo. Salud P\u00fablica: Promoci\u00f3n de la salud y epidemiologia. Vacunaci\u00f3n en adultos. Recomendaciones del 2004. Vacuna de la tos ferina [consultado 30 Sept 2012]. Disponible en: http:\/\/www.msc.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/recoVacunasAdultos.htm"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/655826","article-title":"The present and future control of pertussis","volume":"51","author":"Cherry","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0170","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4161\/hv.6.10.13017","article-title":"Haemophilus influenzae type b conjugate vaccines. Considerations for vaccination schedules and implications for developing countries","volume":"6","author":"Fitzwater","year":"2010","journal-title":"Human Vaccin"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0175","first-page":"741","article-title":"Update on vaccine-derived polioviruses-worldwide. April 2011-June 2012","volume":"61","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0180","first-page":"233","article-title":"Enfermedad meningoc\u00f3cica en Espa\u00f1a. An\u00e1lisis de la temporada 2009-2010","volume":"19","year":"2011","journal-title":"Bol Epidemiol Sem"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0185","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2005.03.045","article-title":"Impact and effectiveness of meningococcal conjugate vaccine following its introduction in Spain","volume":"23","author":"Larrauri","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0190","unstructured":"Direcci\u00f3n General de Salud P\u00fablica y Alimentaci\u00f3n, Consejer\u00eda de Sanidad y Consumo de la Comunidad de Madrid. Infecciones que causan meningitis. 2005 [consultado 30 Sept 2012]. Disponible en: http:\/\/www.madrid.org\/cs\/Satellite?blobtable=MungoBlobs&blobcol=urldata&blobkey=id&blobheadervalue1=filename%3DMarzo2006.pdf&blobwhere=1158572461173&blobheadername1=Content-Disposition&ssbinary=true&blobheader=application%2Fpdf"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0195","unstructured":"Grupo de Trabajo de Enfermedad Meningoc\u00f3cica de la Ponencia de Programa y Registro de Vacunaci\u00f3n. Situaci\u00f3n actual de la enfermedad meningoc\u00f3cica en Espa\u00f1a. Modificaci\u00f3n de la pauta de vacunaci\u00f3n frente a meningococo C [consultado 30 Sept 2012]. Disponible en: http:\/\/www.msc.es\/ciudadanos\/proteccionSalud\/infancia\/docs\/MenC_MARZO_2006.pdf"},{"issue":"Suppl 2","key":"10.1016\/j.anpedi.2012.10.002_bib0200","doi-asserted-by":"crossref","first-page":"B20","DOI":"10.1016\/j.vaccine.2009.04.067","article-title":"Meningococcal C conjugate vaccine: the experience in England and Wales","volume":"27","author":"Campbell","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0205","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0210","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/CVI.00384-09","article-title":"Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine","volume":"17","author":"Borrow","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0215","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/INF.0b013e318262528c","article-title":"Persistence of antibody response following a booster dose of Hib-Menc-TT glycoconjugate vaccine to five years: a follow-up study","volume":"31","author":"Khatami","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0220","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/adc.2007.136036","article-title":"A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddles; a phase 3 open randomised controlled trial","volume":"11","author":"Pace","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0225","unstructured":"JCVI statement on the use of meningococcal C vaccines in the routine childhood immunisation programme, 29 January 2012 [consultado 30 Sept 2012]. Disponible en: http:\/\/webarchive.nationalarchives.gov.uk\/+\/www.dh.gov.uk\/ab\/JCVI\/DH_094744"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0230","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0235","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/CVI.00516-10","article-title":"Safety and immunogenicity of coadministering a combined meningococcal serogroup C an Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age","volume":"18","author":"Miller","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0240","unstructured":"Fichas T\u00e9cnicas de Menigitec, Menjugate, NeisVac C y Menveo. Agencia Espa\u00f1ola de Medicamentos y Productos sanitarios. Ministerio de Sanidad, Servicios Sociales e Igualdad [consultado 30 Sept 2012]. Disponible en: http:\/\/vacunasaep.org\/profesionales\/fichas-tecnicas-vacunas\/resultados?diseases=150"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0245","series-title":"30th Annual Meeting of ESPID","article-title":"Effects of immunization with higher valent pneumococcal conjugate vaccines in German children on numbers of reported IPD cases (1997-2012)","author":"Van der Linden","year":"2012"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0250","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1016\/j.vaccine.2011.09.112","article-title":"Effectiveness of the new serotypes in 13-valent pneumococcal conjugate vaccine","volume":"29","author":"Miller","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0255","unstructured":"Grupo de Trabajo Heracles (datos no publicados)."},{"key":"10.1016\/j.anpedi.2012.10.002_bib0260","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.vaccine.2006.09.019","article-title":"Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine","volume":"25","author":"Madhi","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0265","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1016\/j.vaccine.2008.04.066","article-title":"Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia","volume":"26","author":"Saaka","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0270","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/INF.0b013e318247ef84","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media","volume":"31","author":"Cohen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0275","series-title":"30th Annual Meeting of ESPID","article-title":"Efficacy of 13-valent versus 7-valent pneumococcal conjugate vaccine (Pcv13; Pcv7) in preventing nasopharyngeal colonization: a randomized double-blind trial in Israel)","author":"Dagan","year":"2012"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0280","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/CVI.00317-10","article-title":"Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar","volume":"18","author":"Picazo","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0285","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.vaccine.2010.12.114","article-title":"Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: a 2-year (2007-2009) laboratory-based surveillance in Madrid","volume":"29","author":"Picazo","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0290","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jinf.2009.05.012","article-title":"Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona","volume":"59","author":"Mu\u00f1oz-Almagro","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0295","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1128\/AAC.01494-10","article-title":"Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008","volume":"55","author":"Tarrag\u00f3","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0300","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/cis691","article-title":"Novel pneumococcal serotypes 6C y 6D: anomaly or harbinger","volume":"55","author":"McEllistrem","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijantimicag.2012.03.001","article-title":"Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000-May 2001) and 10 years after (May 2010-May 2011) introduction of conjugate vaccines for child immunisation in Spain","volume":"40","author":"Fenoll","year":"2012","journal-title":"Internat J Antimicrob Agents"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0310","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/CVI.00062-10","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three dose series with routine vaccines in healthy infants and toddlers","volume":"17","author":"Esposito","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0315","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/INF.0b013e3181faa6be","article-title":"Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"RR11","key":"10.1016\/j.anpedi.2012.10.002_bib0320","first-page":"1","article-title":"Prevention of pneumococcal disease among infants and children-Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine","volume":"59","year":"2010","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0325","unstructured":"Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Comunicado sobre la suspensi\u00f3n de la financiaci\u00f3n por parte de la Comunidad de Madrid de la vacunaci\u00f3n frente a neumococo [consultado 30 Sept 2012]. Disponible en: http:\/\/vacunasaep.org\/sala-de-prensa\/comunicado-de-la-asociacion-espanola-de-pediatria-sobre-la-suspension-de-la-financiac"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0330","unstructured":"European Centre for Disease Prevention and Control (ECDC). Measles [consultado 30 Sept 2012]. Disponible en: http:\/\/ecdc.europa.eu\/en\/healthtopics\/measles\/epidemiological_data\/Pages\/annual_epidemiological_reports.aspx"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0335","unstructured":"WHO Weekly epidemiological report. No. 18, 2011 [consultado 30 Sept 2012]. Disponible en: http:\/\/www.who.int\/wer"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0340","unstructured":"European Centre for Disease Prevention and Control (ECDC). Surveillance Report. Measles and rubella monitoring 2012 [consultado 30 Sept 2012]. Disponible en: http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/SUR-Monthly-measles-and-rubella-Aug-2012.pdf"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0345","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.2807\/ese.17.11.20119-en","article-title":"Ongoing measles outbreak in Elche, Spain, 29 January to 9 March 2012","volume":"17","author":"Delgado de los Reyes","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0350","doi-asserted-by":"crossref","first-page":"e1626","DOI":"10.1136\/bmj.c1626","article-title":"Early waning of maternal antibodies in era of measles elimination: longitudinal study","volume":"340","author":"Leuridan","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0355","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1016\/j.vaccine.2012.07.035","article-title":"Measles outbreak in Europe: susceptibility of infants too young to be immunized","volume":"30","author":"Leuridan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0360","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00431-012-1691-y","article-title":"Maternal mumps antibodies in a cohort of children up to the age of 1 year","volume":"171","author":"Leuridan","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0365","unstructured":"ECDC. EUVAC net. Calendarios europeos [consultado 30 Sept 2012]. Disponible en: http:\/\/ecdc.europa.eu\/en\/activities\/surveillance\/euvac\/schedules\/Pages\/schedules.aspx"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0370","unstructured":"Organizaci\u00f3n Panamericana de la Salud. Eliminaci\u00f3n del sarampi\u00f3n. Gu\u00eda Pr\u00e1ctica. 2.a ed. Publicaci\u00f3n cient\u00edfica y t\u00e9cnica, n.\u00b0 605. Washington: OMS; 2007."},{"key":"10.1016\/j.anpedi.2012.10.002_bib0375","unstructured":"Sharland M, editor. Measles. En: Manual of childhood infections. The Blue Book. 3.a ed. Royal College of Paediatrics and Child Health 2011. New York: Oxford Universty Press Inc.; 2011. p. 624\u20137."},{"key":"10.1016\/j.anpedi.2012.10.002_bib0380","series-title":"Red Book; 2012 Report of the Committee on Infectious Diseases","first-page":"1","article-title":"Active and passive immunization","year":"2012"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0385","unstructured":"Calendario de vacunaciones del Consejo Interterritorial del Sistema Nacional de Salud 2007 [consultado 30 Sept 2012]. Disponible en: http:\/\/www.msps.es\/ciudadanos\/proteccionSalud\/infancia\/docs\/c2007.pdf"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0390","unstructured":"Documento de consenso 2011 de Sociedades Cient\u00edficas Espa\u00f1olas. Vacunaci\u00f3n frente al virus del papiloma humano [consultado 30 Sept 2012]. Disponible en: http:\/\/vacunasaep.org\/sites\/vacunasaep.org\/files\/VPH_Consenso_Sociedades_2011.pdf"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0395","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Gobierno de Espa\u00f1a. Coberturas de vacunaci\u00f3n. Datos estad\u00edsticos, 2011 [consultado 30 Sept 2012]. Disponible en: http:\/\/www.msssi.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/coberturas.htm"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0400","series-title":"30th Annual Meeting of ESPID","article-title":"HPV vaccine acceptance in adolescents in Valencia, Spain","author":"Navarro-Illana","year":"2012"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0405","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/jmv.23282","article-title":"Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study","volume":"84","author":"Castellsagu\u00e9","year":"2012","journal-title":"J Med Virol"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0410","unstructured":"Ficha t\u00e9cnica de Gardasil\u00ae (EPAR, \u00faltima actualizaci\u00f3n: 31 de julio de 2012) [consultado 30 Sept 2012]. Disponible en: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000703\/human_med_000805.jsp&mid=WC0b01ac058001d124"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0415","unstructured":"Ficha t\u00e9cnica de Cervarix\u00ae (EPAR, \u00faltima actualizaci\u00f3n: 30 de enero de 2012) [consultado 30 Sept 2012]. Disponible en: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000721\/human_med_000694.jsp&mid=WC0b01ac058001d124"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0420","unstructured":"Ficha t\u00e9cnica Gardasil\u00ae (FDA, \u00faltima actualizaci\u00f3n: 22 de diciembre de 2010) [consultado 30 Sept 2012]. Disponible en: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm237941.htm"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0425","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","article-title":"Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Wheeler","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0430","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years","volume":"199","author":"Brown","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0435","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/INF.0b013e3181c177fb","volume":"29","author":"Vesikari","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0440","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1097\/INF.0b013e31822d28df","volume":"30","author":"Wheeler","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0445","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jadohealth.2011.10.009","article-title":"Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16\/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls","volume":"50","author":"Pedersen","year":"2012","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0450","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-11-13","article-title":"Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review and meta-analysis","volume":"11","author":"Lu","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0455","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1016\/j.vaccine.2010.02.019","article-title":"Post-licensure monitoring of HPV vaccine in the United States","volume":"28","author":"Markowitz","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0460","first-page":"325","article-title":"Global Advisory Committee on Vaccine Safety, report of meeting held 17-18 June 2009","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0465","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2796.2011.02467.x","article-title":"Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine","volume":"271","author":"Chao","year":"2012","journal-title":"J Intern Med"},{"issue":"Suppl 4","key":"10.1016\/j.anpedi.2012.10.002_bib0470","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jadohealth.2010.01.010","article-title":"Human papillomavirus-related disease in men: not just a women's issue","volume":"46","author":"Palefsky","year":"2010","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0475","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males-ACIP, 2011","volume":"60","year":"2011","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0480","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1542\/peds.2011-3865","article-title":"HPV vaccine recommendations","volume":"129","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0485","unstructured":"Department of Heath and Ageing. Australian Government. National immunisation program-Human papillomavirus vaccination for boys [consultado 30 Sept 2012]. Disponible en: http:\/\/www.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/immunise-hpv"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0490","article-title":"Public Health Agency of Canada. Update on human papillomavirus (HPV) vaccines [consultado 30 Sept 2012]","volume":"38","year":"2012","journal-title":"CCDR"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0495","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/j.vaccine.2011.07.096","article-title":"The cost-effectiveness of male HPV vaccination in the United States","volume":"29","author":"Chesson","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0500","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2165\/11599470-000000000-00000","article-title":"The cost effectiveness of human papillomavirus vaccines: a systematic review","volume":"72","author":"Seto","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0505","doi-asserted-by":"crossref","unstructured":"Report of the Second European Expert Meeting on Rotavirus Vaccination. Vaccine. 2012;30:2237\u201344.","DOI":"10.1016\/j.vaccine.2011.12.002"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0510","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008521.pub2","article-title":"Vaccines for preventing rotavirus diarrhoea: vaccines in use","volume":"2","author":"Soares-Weiser","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0515","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2334-12-62","article-title":"Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review","volume":"12","author":"Ogilvie","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0520","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.coviro.2012.05.002","article-title":"Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011","volume":"2","author":"Lopman","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0525","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/infdis\/jir477","article-title":"Unexpected benefits of rotavirus vaccination in the United States","volume":"204","author":"Glass","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0530","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MOP.0b013e32834ee594","article-title":"Effects of vaccine on rotavirus disease in the pediatric population","volume":"24","author":"Dennehy","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0535","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4161\/hv.7.7.15576","article-title":"Effectiveness of rotavirus vaccination in Spain","volume":"7","author":"Martin\u00f3n-Torres","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0540","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.vaccine.2011.11.071","article-title":"Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain","volume":"30","author":"Castilla","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0545","unstructured":"Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios. Nota informativa: Liberaci\u00f3n de lotes de la vacuna Rotateq\u00ae. AEMPS, 4 noviembre del 2010 [consultado 30 Sept 2012]. Disponible en: http:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/calidad\/2010\/NI-circovirus-rotateq_noviembre-2010.htm"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0550","unstructured":"Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios. Informe mensual sobre medicamentos de uso humano y productos sanitarios, enero 2012. Cambios de especial inter\u00e9s sanitario en medicamentos ya autorizados [consultado 30 Sept 2012]. Disponible en: http:\/\/www.aemps.gob.es\/informa\/informeMensual\/2012\/enero\/docs\/informe-mensual_enero-2012.pdf"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0555","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.vaccine.2011.01.088","article-title":"Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia","volume":"29","author":"Buttery","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0560","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil","volume":"364","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0565","first-page":"317","article-title":"Rotavirus vaccine and intussusception: report from an expert consultation","volume":"86","year":"2011","journal-title":"Wkly Epidem Rec"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0570","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jpeds.2011.08.012","article-title":"Trends in intussusception-associated deaths among US infants from 1979-2007","volume":"160","author":"Desai","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0575","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jama.2012.97","article-title":"Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants","volume":"307","author":"Shui","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0580","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archpediatrics.2011.1501","article-title":"Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States","volume":"166","author":"Zickafoose","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0585","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1473-3099(11)70253-5","article-title":"2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis","volume":"12","author":"Tate","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.anpedi.2012.10.002_bib0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/INF.0b013e318270362c","article-title":"Potential intussusception risk versus benefits of rotavirus vaccination in the United States","volume":"32","author":"Desai","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0595","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/INF.0b013e3182490a2c","article-title":"Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase iiib study","volume":"31","author":"Ome\u00f1aca","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0600","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/INF.0b013e3181bbf2a0","article-title":"Decline in varicella related ambulatory visits and hospitalizations in the United States since routine inmunization against varicella","volume":"29","author":"Shah","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0605","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1542\/peds.2010-3385","article-title":"Near elimination of varicella deaths in the US after implementation of the vaccination program","volume":"128","author":"Marin","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0610","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2807\/ese.15.13.19530-en","article-title":"Impact of the routine varicella vaccination programme on varicella epidemiology in Germany","volume":"15","author":"Siedler","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0615","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/INF.0b013e318260cc4d","article-title":"The effect of funded varicella immunization programs on varicella related hospitalizations in IMPACT centers, Canada, 2000-2008","volume":"31","author":"Tan","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0620","doi-asserted-by":"crossref","first-page":"9480","DOI":"10.1016\/j.vaccine.2011.10.022","article-title":"Impact of universal vaccination on the epidemiology of varicella in Veneto","volume":"29","author":"Pozza","year":"2011","journal-title":"Italy Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0625","unstructured":"Comit\u00e9 Asesor de Vacunas de la Comunidad de Madrid. Informe sobre varicela en la Comunidad de Madrid [consultado 30 Sept 2012]. 2010. Disponible en: http:\/\/www.madrid.org"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0630","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4321\/S1137-66272011000200006","article-title":"Impacto de la vacunaci\u00f3n universal frente a la varicela en Navarra, 2006-2010","volume":"34","author":"Garc\u00eda Cenoz","year":"2011","journal-title":"An Sist Sanit Navar"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0635","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella vaccine over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0640","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/522150","article-title":"Varicella disease among vaccinated persons. Clinical and epidemiological characteristics, 1997-2005","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect D"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0645","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1016\/j.vaccine.2012.05.072","article-title":"A varicella outbreak in a school with high one-dose vaccination coverage, Beijing","volume":"30","author":"Lu","year":"2012","journal-title":"China Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0650","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/529043","article-title":"Primary vaccine failure after 1 dose of varicella vaccine in healthy children","volume":"197","author":"Michalik","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0655","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1016\/j.vaccine.2010.02.079","article-title":"Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster","volume":"28","author":"Brisson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0660","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/infdis\/jiq052","article-title":"Effectiveness of 2 doses of varicella vaccine in children","volume":"203","author":"Shapiro","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0665","first-page":"609","article-title":"Evolution of varicella surveillance-selected States, 2000-2010","volume":"61","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0670","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1542\/peds.2007-1089","article-title":"Prevention of varicella: recommendations for use of varicella vaccines in children, including recommendations for a routine 2-dose varicella immunization schedule","volume":"120","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0675","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1086\/522135","article-title":"An economic analysis of the universal varicella vaccination program in the United States","volume":"197","author":"Zhou","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0680","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.vaccine.2011.11.026","article-title":"The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom","volume":"30","author":"Van Hoek","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0685","unstructured":"Consenso sobre la vacunaci\u00f3n frente a la gripe en el personal sanitario, 2012. Documento de Consenso de Sociedades Cient\u00edficas espa\u00f1olas [consultado 30 Sept 2012]. Disponible en: http:\/\/vacunasaep.org\/sites\/vacunasaep.org\/files\/vac_gripe_en_p.sanitario.pdf"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0690","unstructured":"Vacunaci\u00f3n frente a la gripe estacional en la infancia y la adolescencia. Recomendaciones del Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda (CAV-AEP) para la campa\u00f1a 2012-2013 [consultado 30 Sept 2012]. Disponible en: http:\/\/vacunasaep.org\/documentos"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0695","unstructured":"World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season [consultado 30 Sept 2012]. Disponible en: http:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/201202_recommendation.pdf"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0700","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1016\/j.vaccine.2011.08.010","article-title":"Seasonal influenza: the burden of disease in children","volume":"29","author":"Fraaij","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0705","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1743-422X-8-349","article-title":"Viral shedding in children infected by pandemic A\/H1N1\/2009 influenza virus","volume":"8","author":"Esposito","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0710","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/INF.0b013e3181fe37c8","article-title":"Incidence of influenza-related hospitalizations in different age groups of children in Finland: a 16-year study","volume":"30","author":"Silvennoinen","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0715","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa054869","article-title":"The underrecognized burden of influenza in young children","volume":"355","author":"Poehling","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0720","first-page":"CD004879","article-title":"Vaccines for preventing influenza in healthy children","author":"Jefferson","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0725","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1016\/j.vaccine.2011.08.011","article-title":"Effectiveness and safety of influenza vaccination in children: European perspective","volume":"29","author":"Heikkinen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0730","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0735","first-page":"613","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2012-3 influenza season","volume":"61","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0740","unstructured":"Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Fichas t\u00e9cnicas de vacunas antigripales [consultado 30 Sept 2012]. Disponible en: http:\/\/vacunasaep.org\/profesionales\/fichas-tecnicas-vacunas\/resultados?diseases=148"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0745","unstructured":"Vacuna hepatitis A (grupos de riesgo). Circular 15\/1998 de la Direcci\u00f3n General de Farmacia y Productos Sanitarios."},{"key":"10.1016\/j.anpedi.2012.10.002_bib0750","first-page":"346","article-title":"Recomendaciones para el uso de la vacuna de la hepatitis A en guarder\u00edas","volume":"21","year":"1998","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0755","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1542\/peds.2007-1088","article-title":"Hepatitis A vaccine recommendations","volume":"120","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0760","unstructured":"WHO position paper on hepatitis A vaccines-June 2012. Weekly Epidemiol Rec. 2012;87:261\u201376."},{"key":"10.1016\/j.anpedi.2012.10.002_bib0765","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0264-410X(02)00583-2","article-title":"Effectiveness of a mass hepatitis A vaccination program in preadolescents","volume":"21","author":"Dom\u00ednguez","year":"2003","journal-title":"Vaccine"},{"issue":"suppl. 2","key":"10.1016\/j.anpedi.2012.10.002_bib0770","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2893.2008.01030.x","article-title":"Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia","volume":"15","author":"Dom\u00ednguez","year":"2008","journal-title":"Spain J Viral Hepat"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0775","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.vaccine.2008.01.048","article-title":"Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction","volume":"26","author":"Dom\u00ednguez","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0780","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1576-9887(09)71384-6","article-title":"Vacunaci\u00f3n antihepatitis A: \u00bfselectiva o universal?","volume":"10","author":"Rodr\u00edguez","year":"2009","journal-title":"Vacunas"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0785","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1473-3099(09)70324-X","article-title":"Serogroup B meningococcal vaccines-an unfinished story","volume":"10","author":"Sadarangani","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0790","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1586\/erv.11.3","article-title":"Challenges for development of meningococcal vaccines in infants and children","volume":"10","author":"Deasy","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0795","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jama.2012.85","article-title":"Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules. A randomized controlled trial","volume":"307","author":"Gossger","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0800","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(11)61713-3","article-title":"Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b\/3 randomised, observer-blind, placebo-controlled study","volume":"379","author":"Santolaya","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0805","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1128\/CVI.00202-12","article-title":"Inter-laboratory standardization of the sandwich ELISA designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines","volume":"19","author":"Plykaitis","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0810","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(12)70087-7","article-title":"Safety, immunogenicity and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial","volume":"12","author":"Richmond","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0815","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/INF.0b013e31826327e4","article-title":"Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18 to 36 months: a phase 1 randomized controlled clinical trial","volume":"31","author":"Marshall","year":"2012","journal-title":"Pediatr Infect J Dis"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0820","unstructured":"Centers for Disease Control and Prevention (CDC). Catch-up immunization schedule for persons aged 4 months through 18 years who start late or who are more than 1 month behind [consultado 30 Sept 2012]. Disponible en: http:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/child\/catchup-schedule-pr.pdf"},{"key":"10.1016\/j.anpedi.2012.10.002_bib0825","unstructured":"The Australian Immunisation Handbook, 9th ed, 2008. Catch-up -updated July 2009 [consultado 30 Sept 2012]. Disponible en: http:\/\/www.immunise.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/handbook-catchup"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403312004407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403312004407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:35:10Z","timestamp":1787106910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403312004407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":165,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1695403312004407"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2012.10.002","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calendario de vacunaciones de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones 2013","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2012.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}